Search

Search

このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

ホーム
...
研究分野生物医学と臨床科学腫瘍学とがん発生癌治療 (化学療法と放射線療法を除く)
研究分野
生物医学と臨床科学
腫瘍学とがん発生
癌治療 (化学療法と放射線療法を除く)
編集者宛の手紙: 免疫療法後の肝細胞がん患者の完全な応答結果に対する応答基準と局域療法の影響を明らかにする

編集者宛の手紙: 免疫療法後の肝細胞がん患者の完全な応答結果に対する応答基準と局域療法の影響を明らかにする

Tsung-Hao Liu ^1,2, Hung-Chih Yang ^3,4

Tsung-Hao Liu ^1,2, Hung-Chih Yang ^3,4

¹Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
²Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
³Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
⁴Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

⁰Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.

Hepatology Forum +

|

2025年9月4日

|

2025年9月4日

関連する実験動画

Contact us if these videos are not relevant.

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

See all related videos

まとめ

No abstract available on PubMed

関連する実験動画

Contact us これらのビデオが関連しない場合は

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

See all related videos

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies